| # | Title | Journal | Year | Citations |
|---|
| 1 | Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions | American Journal of Transplantation | 2008 | 1,710 |
| 2 | Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index | American Journal of Transplantation | 2006 | 1,624 |
| 3 | Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence | American Journal of Transplantation | 2012 | 1,292 |
| 4 | Diabetes Mellitus after Kidney Transplantation in the United States | American Journal of Transplantation | 2003 | 1,121 |
| 5 | Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era | American Journal of Transplantation | 2004 | 1,072 |
| 6 | Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes | American Journal of Transplantation | 2011 | 997 |
| 7 | Antibody-Mediated Rejection Criteria - an Addition to the Banff ′97 Classification of Renal Allograft Rejection | American Journal of Transplantation | 2003 | 960 |
| 8 | Cancer after Kidney Transplantation in the United States | American Journal of Transplantation | 2004 | 924 |
| 9 | Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report | American Journal of Transplantation | 2004 | 924 |
| 10 | A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study) | American Journal of Transplantation | 2010 | 838 |
| 11 | Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant | American Journal of Transplantation | 2012 | 817 |
| 12 | The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials | American Journal of Transplantation | 2018 | 813 |
| 13 | Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients | American Journal of Transplantation | 2004 | 792 |
| 14 | Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal | American Journal of Transplantation | 2011 | 779 |
| 15 | The Survival Benefit of Liver Transplantation | American Journal of Transplantation | 2005 | 732 |
| 16 | Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups | American Journal of Transplantation | 2010 | 691 |
| 17 | Identifying Specific Causes of Kidney Allograft Loss | American Journal of Transplantation | 2009 | 690 |
| 18 | COVID-19 in solid organ transplant recipients: Initial report from the US epicenter | American Journal of Transplantation | 2020 | 683 |
| 19 | Foreword | American Journal of Transplantation | 2009 | 668 |
| 20 | Development of the New Lung Allocation System in the United States | American Journal of Transplantation | 2006 | 658 |
| 21 | Rational Development of LEA29Y (belatacept), a High‐Affinity Variant of CTLA4‐Ig with Potent Immunosuppressive Properties | American Journal of Transplantation | 2005 | 655 |
| 22 | Evolution of Causes and Risk Factors for Mortality Post‐Liver Transplant: Results of the NIDDK Long‐Term Follow‐Up Study | American Journal of Transplantation | 2010 | 622 |
| 23 | Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure | American Journal of Transplantation | 2009 | 618 |
| 24 | Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction | American Journal of Transplantation | 2005 | 613 |
| 25 | Delayed Graft Function in the Kidney Transplant | American Journal of Transplantation | 2011 | 599 |
| 26 | Expanded criteria donors for kidney transplantation | American Journal of Transplantation | 2003 | 576 |
| 27 | The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology | American Journal of Transplantation | 2017 | 551 |
| 28 | Long-Term Renal Allograft Survival: Have we Made Significant Progress or is it Time to Rethink our Analytic and Therapeutic Strategies? | American Journal of Transplantation | 2004 | 549 |
| 29 | Small-for-Size Syndrome After Partial Liver Transplantation: Definition, Mechanisms of Disease and Clinical Implications | American Journal of Transplantation | 2005 | 544 |
| 30 | A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization | American Journal of Transplantation | 2009 | 540 |
| 31 | Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus | American Journal of Transplantation | 2007 | 530 |
| 32 | Humoral Theory of Transplantation | American Journal of Transplantation | 2003 | 517 |
| 33 | Rituximab, an Anti-CD20 Monoclonal Antibody: History and Mechanism of Action | American Journal of Transplantation | 2006 | 515 |
| 34 | Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients | American Journal of Transplantation | 2011 | 507 |
| 35 | Infection in Organ Transplantation | American Journal of Transplantation | 2017 | 507 |
| 36 | Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study) | American Journal of Transplantation | 2010 | 497 |
| 37 | TGF-beta Induces Foxp3 + T-Regulatory Cells from CD4 + CD25 - Precursors | American Journal of Transplantation | 2004 | 495 |
| 38 | Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF‐Expanded Criteria Based on Preoperative Imaging | American Journal of Transplantation | 2007 | 490 |
| 39 | Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling | American Journal of Transplantation | 2006 | 482 |
| 40 | Early Hepatic Artery Thrombosis after Liver Transplantation: A Systematic Review of the Incidence, Outcome and Risk Factors | American Journal of Transplantation | 2009 | 468 |
| 41 | Hypothermic Machine Preservation in Human Liver Transplantation: The First Clinical Series | American Journal of Transplantation | 2010 | 467 |
| 42 | FTY720: Sphingosine 1-Phosphate Receptor-1 in the Control of Lymphocyte Egress and Endothelial Barrier Function | American Journal of Transplantation | 2004 | 455 |
| 43 | Urine NGAL and IL-18 are Predictive Biomarkers for Delayed Graft Function Following Kidney Transplantation. | American Journal of Transplantation | 2006 | 452 |
| 44 | 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection | American Journal of Transplantation | 2016 | 451 |
| 45 | Cytomegalovirus in Solid Organ Transplantation | American Journal of Transplantation | 2013 | 448 |
| 46 | BK Polyomavirus in Solid Organ Transplantation | American Journal of Transplantation | 2013 | 447 |
| 47 | The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection | American Journal of Transplantation | 2020 | 437 |
| 48 | Immunocompetent T-Cells with a Memory-Like Phenotype are the Dominant Cell Type Following Antibody-Mediated T-Cell Depletion | American Journal of Transplantation | 2005 | 435 |
| 49 | American Society of Transplantation Recommendations for Screening, Monitoring and Reporting of Infectious Complications in Immunosuppression Trials in Recipients of Organ Transplantation | American Journal of Transplantation | 2006 | 434 |
| 50 | Endothelial Gene Expression in Kidney Transplants with Alloantibody Indicates Antibody-Mediated Damage Despite Lack of C4d Staining | American Journal of Transplantation | 2009 | 433 |
